Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Observes adults with mild and moderate asthma in everyday care in Italy

Collects information on adults with mild or moderate asthma over time, in everyday care.

Plain-language title generated from the registry record
Registry title: MANI Real-life Perspective Observatory

Key facts

Where
Genova, ItalySee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 99 years old?

Source: NCT04796844, who can take part

Where in Italy

  • IRCCS Ospedale Policlinico San MartinoGenova, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Societa Italiana di Pneumologia
Trial code
NCT04796844
Record updated
28 November 2023
Original description
The purpose of this registry aims is to collect a large number of patients with mild and moderate asthma in a real-word conditions for a perspective observation of epidemiological evolution of the disease in relation to the therapeutic interventions available currently and in the near future.Read full original descriptionShow less

Mild/Moderate Asthma Network of Italy Observatory

The purpose of this registry aims is to collect a large number of patients with mild and moderate asthma in a real-word conditions for a perspective observation of epidemiological evolution of the disease in relation to the therapeutic interventions available currently and in the near future.

Inclusion: Adult patients; Asthma diagnosis according GINA 2020 algorithm (Annex 1); Patients enrolled in other previous or ongoing observational studies.

Exclusion: Subjects are excluded from this cohort if they exhibit interstitial lung diseases, pulmonary neoplasms, current lung infections, immunological disorders leading to the use of immunosuppressants or continuous treatment with oral steroids; Severe asthma patients according International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. [Chung KF et al. European Respiratory Journal Feb 2014, 43 (2) 343-373; DOI: 10.1183/09031936.00202013 (Annex 2)].

ClinicalTrials.gov NCT04796844